JPS5428813A - Solid preparation containing cell membrane extract substance used as suspension when using same - Google Patents

Solid preparation containing cell membrane extract substance used as suspension when using same

Info

Publication number
JPS5428813A
JPS5428813A JP9587177A JP9587177A JPS5428813A JP S5428813 A JPS5428813 A JP S5428813A JP 9587177 A JP9587177 A JP 9587177A JP 9587177 A JP9587177 A JP 9587177A JP S5428813 A JPS5428813 A JP S5428813A
Authority
JP
Japan
Prior art keywords
suspension
same
cell membrane
preparation containing
solid preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9587177A
Other languages
English (en)
Other versions
JPS631291B2 (ja
Inventor
Yuuichi Yamamura
Ichirou Azuma
Katsusuke Maruiri
Tadashi Aoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP9587177A priority Critical patent/JPS5428813A/ja
Priority to US06/930,409 priority patent/US4543253A/en
Priority to GB7832134A priority patent/GB2002229B/en
Priority to SE7808414A priority patent/SE447629B/sv
Priority to IT26609/78A priority patent/IT1098381B/it
Priority to BE78189775A priority patent/BE869610A/xx
Priority to DK352578A priority patent/DK153443C/da
Priority to AU38791/78A priority patent/AU526788B2/en
Priority to CA000309032A priority patent/CA1118348A/en
Priority to FI782442A priority patent/FI65370C/fi
Priority to NL787808337A priority patent/NL7808337A/xx
Priority to DE19782834893 priority patent/DE2834893A1/de
Priority to CH847978A priority patent/CH643459A5/de
Priority to HU78JU295A priority patent/HU179726B/hu
Priority to FR7823522A priority patent/FR2399844A1/fr
Publication of JPS5428813A publication Critical patent/JPS5428813A/ja
Priority to US06/755,404 priority patent/US4599337A/en
Publication of JPS631291B2 publication Critical patent/JPS631291B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP9587177A 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same Granted JPS5428813A (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same
US06/930,409 US4543253A (en) 1977-08-09 1978-08-02 Solidified pharmaceutical composition comprising cell wall skeleton
GB7832134A GB2002229B (en) 1977-08-09 1978-08-03 Pharmaceutical composition
SE7808414A SE447629B (sv) 1977-08-09 1978-08-04 Till fast form overford farmaceutisk komposition innehallande cellveggskelett av nocardia rubra
IT26609/78A IT1098381B (it) 1977-08-09 1978-08-08 Composizione farmaceutica solida comprendente lo scheletro di pareti cellulari
BE78189775A BE869610A (fr) 1977-08-09 1978-08-08 Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes
FI782442A FI65370C (fi) 1977-08-09 1978-08-09 Foerfarande foer framstaellning av ett fast farmaceutiskt preparat
AU38791/78A AU526788B2 (en) 1977-08-09 1978-08-09 Solidified pharmaceutical composition comprising cell wall skeleton
CA000309032A CA1118348A (en) 1977-08-09 1978-08-09 Solidified pharmaceutical composition comprising cell wall skeleton
DK352578A DK153443C (da) 1977-08-09 1978-08-09 Fremgangsmaade til fremstilling af fast farmaceutisk praeparat indeholdende cellevaegsskelet fra nocardia rubra
NL787808337A NL7808337A (nl) 1977-08-09 1978-08-09 In vaste vorm gebracht, celwandskelet bevattend farma- ceutisch preparaat.
DE19782834893 DE2834893A1 (de) 1977-08-09 1978-08-09 Verfestigtes (festes) pharmazeutisches mittel und verfahren zu seiner herstellung
CH847978A CH643459A5 (de) 1977-08-09 1978-08-09 Mikrobielles zellwandgeruest mit adjuvans- und antitumorwirkung enthaltende, verfestigte pharmazeutische zubereitung und ihre herstellung.
HU78JU295A HU179726B (en) 1977-08-09 1978-08-09 Process for preparing solid pharmaceutical compositions containing cell wall skeleton
FR7823522A FR2399844A1 (fr) 1977-08-09 1978-08-09 Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes
US06/755,404 US4599337A (en) 1977-08-09 1985-07-16 Antiphlogistic/antipyretic/analgesic agents containing theobromine or theophylline derivatives as active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (2)

Publication Number Publication Date
JPS5428813A true JPS5428813A (en) 1979-03-03
JPS631291B2 JPS631291B2 (ja) 1988-01-12

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9587177A Granted JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Country Status (15)

Country Link
US (1) US4543253A (ja)
JP (1) JPS5428813A (ja)
AU (1) AU526788B2 (ja)
BE (1) BE869610A (ja)
CA (1) CA1118348A (ja)
CH (1) CH643459A5 (ja)
DE (1) DE2834893A1 (ja)
DK (1) DK153443C (ja)
FI (1) FI65370C (ja)
FR (1) FR2399844A1 (ja)
GB (1) GB2002229B (ja)
HU (1) HU179726B (ja)
IT (1) IT1098381B (ja)
NL (1) NL7808337A (ja)
SE (1) SE447629B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255436A (ja) * 1986-04-18 1987-11-07 ノルデン・ラボラトリ−ス・インコ−ポレイテツド ワクチン処方
JPH01500752A (ja) * 1986-06-09 1989-03-16 セル・テクノロジー・インコーポレーテッド 生体反応モディファイアー
WO2000003724A1 (fr) 1998-07-16 2000-01-27 Hayashi, Akira Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
WO2005102369A1 (ja) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. 細菌細胞壁骨格成分を含有する製剤
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (ja) * 1974-04-25 1978-07-21 Anvar
BE830486A (fr) * 1974-06-20 1975-12-22 Fractions mycobacteriennes utilisables comme agent antiinfectieux, et procede de preparation
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255436A (ja) * 1986-04-18 1987-11-07 ノルデン・ラボラトリ−ス・インコ−ポレイテツド ワクチン処方
JPH01500752A (ja) * 1986-06-09 1989-03-16 セル・テクノロジー・インコーポレーテッド 生体反応モディファイアー
WO2000003724A1 (fr) 1998-07-16 2000-01-27 Hayashi, Akira Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif

Also Published As

Publication number Publication date
CA1118348A (en) 1982-02-16
SE447629B (sv) 1986-12-01
DK352578A (da) 1979-02-10
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (ja) 1982-08-20
IT1098381B (it) 1985-09-07
US4543253A (en) 1985-09-24
CH643459A5 (de) 1984-06-15
BE869610A (fr) 1979-02-08
IT7826609A0 (it) 1978-08-08
HU179726B (en) 1982-11-29
AU3879178A (en) 1980-02-14
FI65370C (fi) 1984-05-10
FI65370B (fi) 1984-01-31
GB2002229B (en) 1982-05-26
AU526788B2 (en) 1983-02-03
DK153443B (da) 1988-07-18
DK153443C (da) 1988-12-05
DE2834893C2 (ja) 1987-08-27
NL7808337A (nl) 1979-02-13
DE2834893A1 (de) 1979-02-22
GB2002229A (en) 1979-02-21
FI782442A (fi) 1979-02-10
SE7808414L (sv) 1979-02-10
JPS631291B2 (ja) 1988-01-12

Similar Documents

Publication Publication Date Title
ZA781137B (en) Membrane cell
AU505061B2 (en) Porous anode separator
JPS55113272A (en) Electrochemical cell
JPS5435174A (en) Substance transfer membrane and its usage
AU514448B2 (en) Diaphragm cell
GB2054652B (en) Filter press-type electrolytic cell
GB2018496A (en) Porous electrode
JPS5428813A (en) Solid preparation containing cell membrane extract substance used as suspension when using same
ZA781506B (en) Diaphragm cells
GB2004767B (en) Membrane decaffeination
IL60118A0 (en) Electrochemical cell
AU3410378A (en) Membrane separation
IL60386A0 (en) Monaqueous electrochemical cell
IL60102A0 (en) Electrochemical cell
GB2040473B (en) Electrode membrane structure
IL55230A (en) Solid state electrochemical cell
DE3071030D1 (en) Electrolytic membrane cell
AU512250B2 (en) Electrolytic diaphragm cell
JPS5434295A (en) Oxygennion cnductive solid electrolyte
JPS5446884A (en) Crushing of chlorella cell membrane
DE2861835D1 (en) Novel heterocyclic carbothioamides, compositions containing them, their preparation and use
JPS5472437A (en) Preparation of separator for accumulator
ZA805215B (en) (6-pyridazinones and preparation useful as cardiotonics)
AU515471B2 (en) Iron containing cell mass glucose isomerase preparation
GB2022281B (en) Sample cell